JENNIFER HAAS: Open Payments
NPI 1427561372 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 51 payments from 13 companies in 2025. Trend: 2023 $390 · 2024 $1,276 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $518 |
| Madrigal Pharmaceuticals | 5 | $96 |
| Celltrion USA Inc. | 3 | $87 |
| Janssen Biotech, Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Ardelyx, Inc. | 2 | $41 |
| VIVUS LLC | 2 | $35 |
| Novo Nordisk Inc | 1 | $32 |
| GENZYME CORPORATION | 1 | $29 |
| Exact Sciences Corporation | 1 | $25 |
Products named: RINVOQ, MAVYRET, REZDIFFRA, VEGZELMA, LINZESS, SKYRIZI, TREMFYA, OMVOH.
Industry payments across FL — which companies pay providers there.
